211 related articles for article (PubMed ID: 22517775)
41. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
Martinez V; Wang L; Million M; Rivier J; Taché Y
Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
[TBL] [Abstract][Full Text] [Related]
42. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
43. Distribution and chemical coding of corticotropin-releasing factor-immunoreactive neurons in the guinea pig enteric nervous system.
Liu S; Gao N; Hu HZ; Wang X; Wang GD; Fang X; Gao X; Xia Y; Wood JD
J Comp Neurol; 2006 Jan; 494(1):63-74. PubMed ID: 16304680
[TBL] [Abstract][Full Text] [Related]
44. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
[TBL] [Abstract][Full Text] [Related]
45. Peripheral activation of corticotropin-releasing factor receptor 2 inhibits food intake and alters meal structures in mice.
Wang L; Stengel A; Goebel M; Martinez V; Gourcerol G; Rivier J; Taché Y
Peptides; 2011 Jan; 32(1):51-9. PubMed ID: 20969907
[TBL] [Abstract][Full Text] [Related]
46. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
Yin Y; Dong L; Yin D
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e79-87. PubMed ID: 17944898
[TBL] [Abstract][Full Text] [Related]
47. Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines.
Kageyama K; Gaudriault GE; Bradbury MJ; Vale WW
Endocrinology; 2000 Jul; 141(7):2285-93. PubMed ID: 10875227
[TBL] [Abstract][Full Text] [Related]
48. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
[TBL] [Abstract][Full Text] [Related]
49. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.
Stengel A; Goebel M; Wang L; Rivier J; Kobelt P; Mönnikes H; Lambrecht NW; Taché Y
Endocrinology; 2009 Nov; 150(11):4911-9. PubMed ID: 19797401
[TBL] [Abstract][Full Text] [Related]
50. Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies.
Chatzaki E; Murphy BJ; Wang L; Million M; Ohning GV; Crowe PD; Petroski R; Taché Y; Grigoriadis DE
J Neurochem; 2004 Jan; 88(1):1-11. PubMed ID: 14675144
[TBL] [Abstract][Full Text] [Related]
51. Regulation of corticotropin-releasing factor receptor type 2beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells.
Kageyama K; Gaudriault GE; Suda T; Vale WW
Cell Signal; 2003 Jan; 15(1):17-25. PubMed ID: 12401516
[TBL] [Abstract][Full Text] [Related]
52. Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa.
Muramatsu Y; Fukushima K; Iino K; Totsune K; Takahashi K; Suzuki T; Hirasawa G; Takeyama J; Ito M; Nose M; Tashiro A; Hongo M; Oki Y; Nagura H; Sasano H
Peptides; 2000 Dec; 21(12):1799-809. PubMed ID: 11150640
[TBL] [Abstract][Full Text] [Related]
53. Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes.
Ikeda K; Tojo K; Sato S; Ebisawa T; Tokudome G; Hosoya T; Harada M; Nakagawa O; Nakao K
Biochem Biophys Res Commun; 1998 Sep; 250(2):298-304. PubMed ID: 9753624
[TBL] [Abstract][Full Text] [Related]
54. Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins).
Erchegyi J; Wang L; Gulyas J; Samant M; Perrin MH; Lewis K; Miller C; Vaughan J; Donaldson C; Fischer W; Low W; Yakabi S; Karasawa H; Taché Y; Rivier C; Rivier J
J Med Chem; 2016 Feb; 59(3):854-66. PubMed ID: 26789203
[TBL] [Abstract][Full Text] [Related]
55. mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues.
Baigent SM; Lowry PJ
J Mol Endocrinol; 2000 Aug; 25(1):43-52. PubMed ID: 10915217
[TBL] [Abstract][Full Text] [Related]
56. Peripheral CRF activates myenteric neurons in the proximal colon through CRF(1) receptor in conscious rats.
Miampamba M; Maillot C; Million M; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2002 May; 282(5):G857-65. PubMed ID: 11960782
[TBL] [Abstract][Full Text] [Related]
57. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
[TBL] [Abstract][Full Text] [Related]
58. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
59. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats.
Chen CY; Inui A; Asakawa A; Fujino K; Kato I; Chen CC; Ueno N; Fujimiya M
Gastroenterology; 2005 Jul; 129(1):8-25. PubMed ID: 16012930
[TBL] [Abstract][Full Text] [Related]
60. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.
Li C; Vaughan J; Sawchenko PE; Vale WW
J Neurosci; 2002 Feb; 22(3):991-1001. PubMed ID: 11826127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
